We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

The ForeSeeHome Device and the HOME Study A Milestone in the Self-detection of Neovascular Age-Related Macular Degeneration

Dennis P. Han, MD1
[+] Author Affiliations
1The Eye Institute, Medical College of Wisconsin, Milwaukee
JAMA Ophthalmol. 2014;132(10):1167-1168. doi:10.1001/jamaophthalmol.2014.1405.
Text Size: A A A
Published online


Since the beginning of neovascular age-related macular degeneration (AMD) therapy, clinicians have been faced with a dilemma—that treatment was most helpful if choroidal neovascularization (CNV) was detected before visual acuity was affected1 but that identifying patients at this early stage was difficult. Self-detection techniques have been less than satisfactory. For instance, Zaidi et al2 described only a 30% detection rate on a self-detection protocol that included the use of the Amsler grid. Poor results have been attributed to difficulty adhering to a regimen of daily use of the Amsler grid and to the insensitivity of the test in detecting change.3,4 Self-detection methods that register, quantify, and compare macular dysfunction over time have not been available. Ideally, an instrument that would integrate these features could be developed. The Home Monitoring of the Eye (HOME) study is a culmination of such an effort.5

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles